C
Crinetics Pharmaceuticals
Novel therapeutics targeting peptide hormone receptors for the treatment of endocrine-related diseases and cancers
About Crinetics Pharmaceuticals
Crinetics Pharmaceuticals is a clinical-stage pharmaceutical company specializing in the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company operates in the biopharmaceutical market, targeting conditions that have limited treatment options. Crinetics serves patients with rare endocrine disorders, such as acromegaly, by developing innovative oral treatments like CRN00808, which is currently in Phase 2 clinical trials. The business model focuses on advancing drug candidates through clinical trials and obtaining regulatory approvals to bring these therapies to market. Revenue is generated through the commercialization of approved drugs and potential partnerships or licensing agreements with larger pharmaceutical companies.
Source: Dealroom company dataAt a glance
- Founded
- 2008
- Headquarters
- San Diego, United States
- Listing
- IPO 2018
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tier
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
National Institutes of Health
National Eye Institute
Series A6 investors entered at this stage
Series B and later12 investors entered at this stage
- ACAdage Capital
- ECEcoR1 Capital
- INInvus
Janus Henderson Investors
OrbiMed- DMDriehaus Capital Management
- GIGordonMD Global Investment
- FMFirst Light Asset Management
- PBParadigm BioCapital
Perceptive Advisors- RCRock Springs Capital
RA Capital Management
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
46 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Crinetics Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Crinetics Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.